Milrinone is a phosphodiesterase inhibitor, a cardiotonic drug with positive inotropic and vasodilating effects, which can be used to treat acute or chronic refractory congestive heart failure.
Millinone is a cardiotropic drug, belonging to phosphodiesterase inhibitors. By inhibiting phosphodiesterase, the drug can increase the concentration of cyclic adenosine phosphate and calcium in cardiomyocytes, thereby effectively strengthening myocardial contractility and increasing cardiac output, so as to exert positive muscle strength. In addition, Milrinone can also play a vasodilator role by directly acting on the small arteries.
milrinone supports ventricular functioning of the heart by decreasing the degradation of cAMP and thus increasing phosphorylation levels of many components in the heart that contribute to contractility and heart rate. Milrinone use following cardiac surgery has been under some debate because of the potential increase risk of postoperative atrial arrhythmias. However, in the short term milrinone has been deemed beneficial to those experiencing heart failure and an effective therapy to maintain heart function following cardiac surgeries. There is no evidence of any long term beneficial effects on survival.
Milrinone, is a medication used in patients who have heart failure. It is a phosphodiesterase 3 inhibitor that works to increase the heart's contractility and decrease pulmonary vascular resistance. Milrinone also works to vasodilate which helps alleviate increased pressures (afterload) on the heart, thus improving its pumping action. While it has been used in people with heart failure for many years, recent studies suggest that milrinone may exhibit some negative side effects that have caused some debate about its use clinically.
Overall, milrinone supports ventricular functioning of the heart by decreasing the degradation of cAMP and thus increasing phosphorylation levels of many components in the heart that contribute to contractility and heart rate. Milrinone use following cardiac surgery has been under some debate because of the potential increase risk of postoperative atrial arrhythmias. However, in the short term milrinone has been deemed beneficial to those experiencing heart failure and an effective therapy to maintain heart function following cardiac surgeries. There is no evidence of any long term beneficial effects on survival.
Számos kiváló minőségű gyárunk van mély együttműködéssel, amelyek kiváló minőségű termékeket és versenyképes árakat biztosítanak Önnek. Tömeges vásárlás esetén is tudunk kedvezményt adni. És sok professzionális szállítmányozó céggel együttműködünk, biztonságosan és zökkenőmentesen kézbesítjük a termékeket. A szállítási idő a fizetés visszaigazolásától számított 3-20 nap.
Elemzés
|
Leírás
|
Eredmény
|
Test method
|
Physical Description
|
|
|
|
Kinézet
|
White Powder
|
White Powder |
Visual
|
Szag
|
Characteristic
|
Characteristic
|
Organoleptic
|
Particle size
|
90% pass 80 mesh
|
90% pass 80 mesh
|
80 Mesh Screen
|
Chemical Tests
|
|
|
|
Assay (Lutein)
|
99%
|
90.15%
|
HPLC
|
Loss on drying
|
5.0% Max
|
1.82%
|
5g/105ºC/2hrs
|
Ash Contents
|
5.0% Max
|
1.12%
|
2g/525ºC/3hrs
|
Residual Solvents
|
50.0 ppm, Only Ethanol
|
<30.0 ppm
|
/
|
Heavy metals
|
5.0 ppm Max
|
<3.0 ppm
|
AAS
|
Lead
|
3.0 ppm Max
|
<1.0 ppm
|
AAS
|
Arsenic
|
3.0 ppm Max
|
<1.0 ppm
|
AAS
|
Microbiology Control
|
|
|
|
Total Bacteria Count
|
1,000cfu/g Max
|
<280cfu/g
|
AOAC
|
Yeast & Mold
|
100cfu/g Max
|
<10cfu/g
|
AOAC
|
Coliform
|
30.0 MPN/g Max
|
<3.0 MPN/g
|
AOAC
|
Következtetés
|
Complies with the standards.
|
||
General Status
|
Non-GMO, ISO Certificated.
|
Milrinone is a PDE3 (phosphodiesterase 3) inhibitor that exhibits vasodilator and positive inotropic effects. Milrinone's positive inotropic activity can be inhibited by carbachol (sc-202092). Research indicates that Milrinone can increase platelets and enhance cAMP levels. Milrinone is an inhibitor of PDE3A and PDE3B.
Milrinone, commonly known and marketed as the drug Primacor, is a medication used in patients suffering from heart failure. Milrinone is a phosphodiesterase 3 inhibitor that works to increase the heart's contractility. Milrinone also works to vasodilate vessels which helps alleviate increased pressures (afterload) on the heart, thus improving its pumping action. Milrinone has been used in those suffering from heart failure for many years.
1. Ön egy gyár vagy egy kereskedelmi vállalat?
Az ipart és a kereskedelmet integráló vállalat vagyunk, amely egyablakos szolgáltatást nyújt. Az OEM-et el lehet fogadni.
2. Adsz mintákat? Ingyenes vagy extra?
Ingyenes minták. A minta szállítási díját Önnek kell fizetnie.
3. Van-e minőség-ellenőrzéssel kapcsolatos tanúsítványa?
ISO 9001:2008 minősítés a minőség biztosítása érdekében.
4. Mit kell megadnom az árajánlat kéréséhez?
Kérjük, tájékoztasson minket a termék típusáról, amelyre szüksége van, a rendelési mennyiségről, a címről és a konkrét követelményekről. Az árajánlatot időben referenciaként készítjük el.
5. Milyen fizetési módot részesít előnyben? Milyen feltételeket fogadnak el?
Elfogadott szállítási feltételek: FOB,CFR,CIF,EXW;
Elfogadott fizetési pénznem: USD;
Elfogadott fizetési mód: T/T, Western Union; Paypal, Trade Assurance.
Beszélt nyelv: angol.
Termékkategóriák